Literature DB >> 768764

Immune complexes in hepatocytic nuclei of HB ag-positive chronic hepatitis.

M A Gerber, E Sarno, S J Vernace.   

Abstract

To localize immune complexes in viral hepatitis Type B and to assess their pathogenic role, we examined by the direct fluorescent-antibody technic 21 liver specimens with hepatitis B core antigen (HBc Ag) in hepatocytic nuclei from 10 patients with HBs Ag-seropositive acute viral hepatitis and from 11 patients with HBs Ag-seropositive chronic active hepatitis. IgG with in vitro fixation of complement was demonstrated in HBc Ag-containing hepatocytic nuclei of all patients with chronic active, but not in those with acute viral hepatitis. All patients except for one had antibody to HBc Ag in the serum as determined by indirect immunofluorescence. The evidence suggests that intranuclear IgG in chronic active hepatitis has anti-HBc specificity and forms immune complexes with HBc Ag. The binding of IgG to intranuclear HBc Ag might have pathogenic importance in chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 768764     DOI: 10.1056/NEJM197604222941704

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  7 in total

1.  Effect of specific and nonspecific immune complexes on injury of intact hepatocytes in vitro.

Authors:  H Kawanishi
Journal:  Experientia       Date:  1983-07-15

2.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

3.  Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.

Authors:  R C Gupta
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

4.  Non-specificity of circulating immune complexes in patients with acute and chronic liver disease.

Authors:  C K Abrass; W A Border; G Hepner
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

5.  Hepatitis B core antigen immune complexes in the liver of hepatitis B patients.

Authors:  M B Ray; V J Desmet; A F Bradburne; J Desmyter; J Fevery; J De Groote
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

6.  In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.

Authors:  J V Wells; J Webb; M Van Deventer; B Fry; K M Pollard; J Raftos; W Monk; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

7.  Electron microscopy of hepatitis B virus components in chronic active liver disease.

Authors:  R De Vos; M B Ray; V J Desmet
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.